J&J, 3M Urge Congress To Back PTAB Discretionary Denials
Johnson & Johnson, 3M and others penned a letter to Congress on Monday praising the Patent Trial and Appeal Board's practice of using its discretion to deny patent reviews due to...To view the full article, register now.
Already a subscriber? Click here to view full article